E-health solutions for cardiac patients supported by Polish Cardiac Society
Innovations for Polish patients
Project NOMED-AF is co-financed by National Center for Research and Development in the Strategic Program "Prevension and Therapy of Civilization-Related Diseases" — STRATEGMED II. Project is conducted by Polish interdisciplinary Consortium:
Silesian Park of Medical Technology Kardio-Med Silesia
Leader of the Project
Medical University
of Warsaw
Medical University
of Gdansk
Jagiellonian University
Collegium Medicum
Pomeranian Medical University
in Szczecin
Institute of Medical Technology
and Equipment ITAM
Comarch Healthcare
— Technology Partner
Project is conducted under auspices Of Ministry Of Health.
The objective of the project was to create and implement into clinical practice long-term non-invasive system of ECG monitoring, enabling early detection of atrial fibrillation (AF), especially asymptomatic (silent) AF across large cohort population aged <65 years. AF is the most common arrhythmia its prevalence grows with age. It increases risk of ischemic stroke (IS) by 5-fold and is suspected to be responsible for 30% of all IS. Exact percentage of AF patients, especially elderly is still investigated in many countries. Although silent AF is considered to be the same risk factor for IS as symptomatic arrhythmia, data on its prevalence is limited. Standard methods of ECG monitoring fail to diagnose AF in patients at AF risk due to limited or not continuous monitoring time. Project NOMED-AF was implemented from July 2015 till June 2019. In its first Stage, long-term System for recording and teletransmission, consisting of mobile long-term ECG vest. recorders. docking station and monitoring platform comprising dedicated automatic ECG analysis software was constructed.
The system was validated in the second phase of the project. The third stage was epidemiological study with total number of 3014 patients aged > 65 years, randomly choosen by Polish Ministry of Digital Affairs. The patients were in telemonitoring up to 30-days. ECG signal of every patient was transmitted every 24-hours to the platform. After immediate automatic analysis was visualized in the Kardic-Med Silesia Telemonitoring Center and assessed by qualified medical staff to confirm AF episodes. Project included also 12-month follow-up of patients participated in epidemiological study.
The vest system and ECG analysis software were validated according to the project protocol. Fulfilling the validation criteria: > 70% sensitivity of AF detection and the ratio of real signal acquisition time to scheduled time no less than 90%, it was approved for use in epidemiological study.
< previous
next >
